Structure

InChI Key UDSFVOAUHKGBEK-CNQKSJKFSA-N
Smile CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChI
InChI=1S/C30H48O3/c1-4-5-6-7-8-9-10-11-12-28(32)33-27-16-15-25-24-14-13-22-21-23(31)17-19-29(22,2)26(24)18-20-30(25,27)3/h21,24-27H,4-20H2,1-3H3/t24-,25-,26-,27-,29-,30-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C30H48O3
Molecular Weight 456.71
AlogP 7.96
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 10.0
Polar Surface Area 43.37
Molecular species NEUTRAL
Aromatic Rings 0.0
Heavy Atoms 33.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Androgen Receptor agonist FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hypogonadism 4 D007006 ClinicalTrials
Malnutrition 3 D044342 ClinicalTrials
Respiratory Insufficiency 3 D012131 ClinicalTrials
Aging 3 D000375 ClinicalTrials
Spinal Cord Injuries 2 D013119 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Sexual Dysfunction, Physiological 2 D012735 ClinicalTrials
Coronary Disease 2 D003327 ClinicalTrials

Related Entries

MCS

Scaffolds

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
22.5
Respiratory, thoracic and mediastinal disorders
12.2
Injury, poisoning and procedural complications
10.13
Vascular disorders
8.63
Nervous system disorders
6.86
Cardiac disorders
6.55
Skin and subcutaneous tissue disorders
6.26
Investigations
5.71
Psychiatric disorders
4.73
Gastrointestinal disorders
3.61
Musculoskeletal and connective tissue disorders
2.54
Reproductive system and breast disorders
2.04

Cross References

Resources Reference
CAS NUMBER 5949-44-0
ChEBI 135741
ChEMBL CHEMBL2107067
DrugBank DB13946
DrugCentral 2608
FDA SRS H16A5VCT9C
PubChem 65157
SureChEMBL SCHEMBL147620
ZINC ZINC000008214690